Expression studies of two novel in CIS-mutations identified in an intermediate case of Hunter syndrome

Verena Ricci, Mirella Filocamo, Stefano Regis, Fabio Corsolini, Marina Stroppiano, Marco Di Duca, Rosanna Gatti

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Hunter syndrome (Mucopolysaccharidosis type II) is a rare X-linked recessive lysosomal storage disorder caused by the deficiency of the enzyme iduronate-2-sulfatase (IDS). To date, more than 200 different mutations have been reported in the IDS gene, located on Xq27.3-q28. Here, we report two new mutations (M488I and G489A) identified in hemizygosity in an Italian Hunter patient. Their "in vitro" expression by COS 7 cells was carried out in order to evaluate their functional consequence on enzyme activity as well as their possible cumulative effect on the malfunctioning of the protein. The results obtained enabled us to confirm the G489A mutation as causative. The M488I mutation, however, could not be unequivocally considered as causing disease because of its residual activity. Although a cumulative effect of the two mutations can be excluded "in vitro," we are cautious about drawing a conclusion with regard to the possible role that the two mutations could have played "in vivo" in modulating the phenotype of the patient. Finally, the knowledge of the molecular defect of the patient has enabled us to identify the carriers, providing reliable genetic counselling to the females of the family.

Original languageEnglish
Pages (from-to)84-87
Number of pages4
JournalAmerican Journal of Medical Genetics
Volume120 A
Issue number1
Publication statusPublished - Jul 1 2003

Fingerprint

Mucopolysaccharidosis II
Mutation
Iduronate Sulfatase
Mucopolysaccharidosis I
COS Cells
Genetic Counseling
Enzymes
Phenotype
Genes

Keywords

  • COS cells
  • Hunter syndrome
  • Iduronate-2-sulfatase
  • Mucopolysaccharidosis type II
  • Transient expression

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Expression studies of two novel in CIS-mutations identified in an intermediate case of Hunter syndrome. / Ricci, Verena; Filocamo, Mirella; Regis, Stefano; Corsolini, Fabio; Stroppiano, Marina; Di Duca, Marco; Gatti, Rosanna.

In: American Journal of Medical Genetics, Vol. 120 A, No. 1, 01.07.2003, p. 84-87.

Research output: Contribution to journalArticle

@article{7143eefc6d8d4499a7c035ec40997d40,
title = "Expression studies of two novel in CIS-mutations identified in an intermediate case of Hunter syndrome",
abstract = "Hunter syndrome (Mucopolysaccharidosis type II) is a rare X-linked recessive lysosomal storage disorder caused by the deficiency of the enzyme iduronate-2-sulfatase (IDS). To date, more than 200 different mutations have been reported in the IDS gene, located on Xq27.3-q28. Here, we report two new mutations (M488I and G489A) identified in hemizygosity in an Italian Hunter patient. Their {"}in vitro{"} expression by COS 7 cells was carried out in order to evaluate their functional consequence on enzyme activity as well as their possible cumulative effect on the malfunctioning of the protein. The results obtained enabled us to confirm the G489A mutation as causative. The M488I mutation, however, could not be unequivocally considered as causing disease because of its residual activity. Although a cumulative effect of the two mutations can be excluded {"}in vitro,{"} we are cautious about drawing a conclusion with regard to the possible role that the two mutations could have played {"}in vivo{"} in modulating the phenotype of the patient. Finally, the knowledge of the molecular defect of the patient has enabled us to identify the carriers, providing reliable genetic counselling to the females of the family.",
keywords = "COS cells, Hunter syndrome, Iduronate-2-sulfatase, Mucopolysaccharidosis type II, Transient expression",
author = "Verena Ricci and Mirella Filocamo and Stefano Regis and Fabio Corsolini and Marina Stroppiano and {Di Duca}, Marco and Rosanna Gatti",
year = "2003",
month = "7",
day = "1",
language = "English",
volume = "120 A",
pages = "84--87",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Expression studies of two novel in CIS-mutations identified in an intermediate case of Hunter syndrome

AU - Ricci, Verena

AU - Filocamo, Mirella

AU - Regis, Stefano

AU - Corsolini, Fabio

AU - Stroppiano, Marina

AU - Di Duca, Marco

AU - Gatti, Rosanna

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Hunter syndrome (Mucopolysaccharidosis type II) is a rare X-linked recessive lysosomal storage disorder caused by the deficiency of the enzyme iduronate-2-sulfatase (IDS). To date, more than 200 different mutations have been reported in the IDS gene, located on Xq27.3-q28. Here, we report two new mutations (M488I and G489A) identified in hemizygosity in an Italian Hunter patient. Their "in vitro" expression by COS 7 cells was carried out in order to evaluate their functional consequence on enzyme activity as well as their possible cumulative effect on the malfunctioning of the protein. The results obtained enabled us to confirm the G489A mutation as causative. The M488I mutation, however, could not be unequivocally considered as causing disease because of its residual activity. Although a cumulative effect of the two mutations can be excluded "in vitro," we are cautious about drawing a conclusion with regard to the possible role that the two mutations could have played "in vivo" in modulating the phenotype of the patient. Finally, the knowledge of the molecular defect of the patient has enabled us to identify the carriers, providing reliable genetic counselling to the females of the family.

AB - Hunter syndrome (Mucopolysaccharidosis type II) is a rare X-linked recessive lysosomal storage disorder caused by the deficiency of the enzyme iduronate-2-sulfatase (IDS). To date, more than 200 different mutations have been reported in the IDS gene, located on Xq27.3-q28. Here, we report two new mutations (M488I and G489A) identified in hemizygosity in an Italian Hunter patient. Their "in vitro" expression by COS 7 cells was carried out in order to evaluate their functional consequence on enzyme activity as well as their possible cumulative effect on the malfunctioning of the protein. The results obtained enabled us to confirm the G489A mutation as causative. The M488I mutation, however, could not be unequivocally considered as causing disease because of its residual activity. Although a cumulative effect of the two mutations can be excluded "in vitro," we are cautious about drawing a conclusion with regard to the possible role that the two mutations could have played "in vivo" in modulating the phenotype of the patient. Finally, the knowledge of the molecular defect of the patient has enabled us to identify the carriers, providing reliable genetic counselling to the females of the family.

KW - COS cells

KW - Hunter syndrome

KW - Iduronate-2-sulfatase

KW - Mucopolysaccharidosis type II

KW - Transient expression

UR - http://www.scopus.com/inward/record.url?scp=0041821844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041821844&partnerID=8YFLogxK

M3 - Article

C2 - 12794697

AN - SCOPUS:0041821844

VL - 120 A

SP - 84

EP - 87

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 1

ER -